“The addition of rituximab R ), an anti-CD20 antibody, was shown to increase the effectiveness of cyclophosphamide, doxorubicin, vincristine , and prednisone (CHOP) chemotherapy in patients with diffuse large B cell non-Hodgkin lymphoma (DLBCL) [13].”